More Than Compliance: Managing The Challenges Of Controlled Substance Manufacturing

By Josh Hoerner, General Manager Siegfried Acceleration Hub Athens, US

Manufacturing controlled substances requires far more than meeting basic regulatory requirements. From early-stage development through commercial production, organizations must navigate a complex framework of DEA regulations, quota management, documentation standards, security measures, and global trade requirements designed to ensure patient access while preventing diversion.

Success depends on integrating compliance into every aspect of operations. This includes maintaining detailed chain-of-custody processes, implementing rigorous employee screening programs, establishing precise inventory controls, and creating documentation systems that account for every milligram of material. As development programs advance, additional challenges emerge around secure storage, international shipping, export permits, and coordination with country-specific regulatory authorities.

For companies evaluating manufacturing strategies, expertise in controlled substance regulations can be as important as technical development capabilities. Understanding how regulatory expectations affect supply planning, clinical trial support, and global distribution helps reduce risk, avoid delays, and ensure continuity throughout the product lifecycle. Read the full article to explore the operational and regulatory considerations shaping controlled substance manufacturing today.